1. Home
  2. PLSE vs PRLB Comparison

PLSE vs PRLB Comparison

Compare PLSE & PRLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • PRLB
  • Stock Information
  • Founded
  • PLSE 2014
  • PRLB 1999
  • Country
  • PLSE United States
  • PRLB United States
  • Employees
  • PLSE N/A
  • PRLB N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • PRLB Metal Fabrications
  • Sector
  • PLSE Health Care
  • PRLB Industrials
  • Exchange
  • PLSE Nasdaq
  • PRLB Nasdaq
  • Market Cap
  • PLSE 1.2B
  • PRLB 1.1B
  • IPO Year
  • PLSE 2016
  • PRLB 2012
  • Fundamental
  • Price
  • PLSE $23.57
  • PRLB $43.14
  • Analyst Decision
  • PLSE
  • PRLB Buy
  • Analyst Count
  • PLSE 0
  • PRLB 4
  • Target Price
  • PLSE N/A
  • PRLB $40.33
  • AVG Volume (30 Days)
  • PLSE 127.7K
  • PRLB 190.5K
  • Earning Date
  • PLSE 03-27-2025
  • PRLB 02-07-2025
  • Dividend Yield
  • PLSE N/A
  • PRLB N/A
  • EPS Growth
  • PLSE N/A
  • PRLB N/A
  • EPS
  • PLSE N/A
  • PRLB 0.94
  • Revenue
  • PLSE N/A
  • PRLB $504,188,000.00
  • Revenue This Year
  • PLSE N/A
  • PRLB $1.06
  • Revenue Next Year
  • PLSE N/A
  • PRLB $2.84
  • P/E Ratio
  • PLSE N/A
  • PRLB $45.82
  • Revenue Growth
  • PLSE N/A
  • PRLB 1.97
  • 52 Week Low
  • PLSE $6.60
  • PRLB $25.76
  • 52 Week High
  • PLSE $23.62
  • PRLB $45.15
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 59.71
  • PRLB 66.11
  • Support Level
  • PLSE $17.35
  • PRLB $39.70
  • Resistance Level
  • PLSE $22.05
  • PRLB $42.54
  • Average True Range (ATR)
  • PLSE 1.22
  • PRLB 1.28
  • MACD
  • PLSE 0.26
  • PRLB 0.40
  • Stochastic Oscillator
  • PLSE 65.91
  • PRLB 96.27

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About PRLB Proto Labs Inc. Common stock

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. The majority of its revenue is derived from the United States of America.

Share on Social Networks: